Share Price and Basic Stock Data
Last Updated: December 9, 2025, 12:17 pm
| PEG Ratio | 0.27 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Kuantum Papers Ltd operates in the paper and paper products industry, a sector that has been experiencing fluctuating demand due to various economic factors. The company reported sales of ₹1,310 Cr for the fiscal year ending March 2023, an impressive increase from ₹830 Cr in the previous year. However, the sales figures seem to have peaked, with a notable decline to ₹1,211 Cr in FY 2024 and an even more subdued ₹1,107 Cr anticipated for FY 2025. This trend reflects a broader challenge within the industry, as shifting consumer preferences and global supply chain disruptions have impacted demand. Notably, the quarterly sales figures also exhibit volatility, with recent quarters showing a downward trajectory, such as ₹298 Cr in September 2023, down from ₹351 Cr in December 2022. Investors should closely monitor these trends as they could indicate a potential slowdown in growth.
Profitability and Efficiency Metrics
Profitability remains a focal point for Kuantum Papers, evidenced by its recent net profit of ₹89 Cr. The company has managed to maintain a reasonable operating profit margin of 18%, though this has shown signs of weakening, particularly in the last few quarters, where margins dipped to 21% in March 2024 and further to 18% in June 2025. The efficiency metrics also paint a mixed picture; the return on equity (ROE) stands at 10.1%, while return on capital employed (ROCE) is slightly better at 11.4%. These returns appear somewhat conservative in comparison to industry standards, suggesting that while the company is profitable, there may be room for improvement in asset utilization and cost management. Additionally, the interest coverage ratio of 6.33x indicates that the company is comfortably managing its interest obligations, a positive sign amid increasing financial scrutiny.
Balance Sheet Strength and Financial Ratios
Kuantum Papers presents a balance sheet that reveals both strengths and potential vulnerabilities. With total borrowings reported at ₹654 Cr against reserves of ₹1,204 Cr, the company appears to have a solid cushion to manage its debt. The debt-to-equity ratio of 0.53 suggests a moderate level of leverage, which is typical for the industry. However, the current ratio of 0.83 raises some eyebrows, indicating that the company may face liquidity challenges in meeting short-term obligations. Furthermore, the price-to-book value ratio of 0.72x signifies that the stock is trading at a discount to its book value, which could appeal to value investors. Nevertheless, the declining cash conversion cycle, which stood at 107 days, hints at potential inefficiencies in inventory and receivables management, warranting further investigation.
Shareholding Pattern and Investor Confidence
The shareholding structure of Kuantum Papers reflects a strong promoter presence, with promoters holding 70.31% of the shares. This level of ownership often instills confidence among retail investors, as it suggests commitment from those at the helm. However, the absence of foreign institutional investors (FIIs) and domestic institutional investors (DIIs) may indicate a lack of broader market enthusiasm. The public shareholding stands at 29.68%, and the number of shareholders has steadily increased from 11,678 in December 2022 to 22,729 by March 2025, which is a positive sign. The recent dividend payout ratio of 22.72% also highlights a commitment to returning capital to shareholders, although the payout has been inconsistent in previous years, raising questions about the company’s dividend reliability.
Outlook, Risks, and Final Insight
Looking ahead, Kuantum Papers faces a blend of opportunities and challenges. On one hand, the company’s established market presence and strong promoter backing provide a solid foundation. However, the declining sales and profitability margins raise concerns about its ability to sustain growth in a competitive environment. Investors should also be wary of the liquidity issues suggested by the current ratio and the volatility in sales figures, which may reflect broader economic uncertainties. The company’s ability to adapt to changing market dynamics and improve operational efficiencies will be crucial in determining its future trajectory. Thus, potential investors might consider Kuantum Papers as a speculative play, weighing the inherent risks against the potential for recovery in a sector that remains essential yet unpredictable.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors of Kuantum Papers Ltd
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Mohit Paper Mills Ltd | 46.0 Cr. | 32.9 | 46.0/25.4 | 7.21 | 39.0 | 0.00 % | 12.0 % | 13.6 % | 10.0 |
| Gratex Industries Ltd | 5.76 Cr. | 19.0 | 28.4/14.2 | 52.4 | 12.2 | 0.00 % | 3.85 % | 2.52 % | 10.0 |
| Ganga Papers India Ltd | 89.8 Cr. | 83.3 | 118/75.1 | 59.5 | 29.0 | 0.00 % | 6.44 % | 5.19 % | 10.0 |
| Encode Packaging India Ltd | 4.10 Cr. | 13.0 | 19.0/10.8 | 10.3 | 0.00 % | 2.06 % | 2.12 % | 10.0 | |
| Cella Space Ltd | 27.4 Cr. | 13.6 | 19.3/9.11 | 28.6 | 10.3 | 0.00 % | 10.7 % | % | 10.0 |
| Industry Average | 746.91 Cr | 76.54 | 45.14 | 107.44 | 0.72% | 9.32% | 134.80% | 6.50 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 274 | 341 | 351 | 344 | 313 | 298 | 301 | 299 | 281 | 279 | 270 | 277 | 223 |
| Expenses | 213 | 242 | 246 | 230 | 203 | 218 | 222 | 235 | 209 | 218 | 220 | 217 | 183 |
| Operating Profit | 61 | 99 | 105 | 114 | 109 | 81 | 79 | 64 | 72 | 61 | 50 | 60 | 40 |
| OPM % | 22% | 29% | 30% | 33% | 35% | 27% | 26% | 21% | 25% | 22% | 19% | 22% | 18% |
| Other Income | -62 | 1 | 1 | 0 | 1 | 1 | 1 | 3 | 1 | 2 | 2 | 1 | 1 |
| Interest | 18 | 20 | 18 | 16 | 11 | 12 | 11 | 8 | 9 | 9 | 10 | 10 | 10 |
| Depreciation | 11 | 11 | 11 | 12 | 12 | 12 | 12 | 12 | 13 | 13 | 14 | 15 | 15 |
| Profit before tax | -31 | 69 | 77 | 87 | 87 | 57 | 56 | 46 | 51 | 40 | 28 | 36 | 16 |
| Tax % | 27% | 24% | 26% | 25% | 25% | 26% | 25% | 27% | 25% | 25% | 26% | 28% | 26% |
| Net Profit | -39 | 53 | 57 | 65 | 65 | 43 | 42 | 34 | 38 | 30 | 21 | 26 | 12 |
| EPS in Rs | -4.45 | 6.04 | 6.56 | 7.45 | 7.46 | 4.89 | 4.83 | 3.88 | 4.38 | 3.43 | 2.40 | 2.99 | 1.38 |
Last Updated: August 20, 2025, 7:55 am
Below is a detailed analysis of the quarterly data for Kuantum Papers Ltd based on the most recent figures (Jun 2025) and their trends compared to the previous period:
- For Sales, as of Jun 2025, the value is 223.00 Cr.. The value appears to be declining and may need further review. It has decreased from 277.00 Cr. (Mar 2025) to 223.00 Cr., marking a decrease of 54.00 Cr..
- For Expenses, as of Jun 2025, the value is 183.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 217.00 Cr. (Mar 2025) to 183.00 Cr., marking a decrease of 34.00 Cr..
- For Operating Profit, as of Jun 2025, the value is 40.00 Cr.. The value appears to be declining and may need further review. It has decreased from 60.00 Cr. (Mar 2025) to 40.00 Cr., marking a decrease of 20.00 Cr..
- For OPM %, as of Jun 2025, the value is 18.00%. The value appears to be declining and may need further review. It has decreased from 22.00% (Mar 2025) to 18.00%, marking a decrease of 4.00%.
- For Other Income, as of Jun 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 1.00 Cr..
- For Interest, as of Jun 2025, the value is 10.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 10.00 Cr..
- For Depreciation, as of Jun 2025, the value is 15.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 15.00 Cr..
- For Profit before tax, as of Jun 2025, the value is 16.00 Cr.. The value appears to be declining and may need further review. It has decreased from 36.00 Cr. (Mar 2025) to 16.00 Cr., marking a decrease of 20.00 Cr..
- For Tax %, as of Jun 2025, the value is 26.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Mar 2025) to 26.00%, marking a decrease of 2.00%.
- For Net Profit, as of Jun 2025, the value is 12.00 Cr.. The value appears to be declining and may need further review. It has decreased from 26.00 Cr. (Mar 2025) to 12.00 Cr., marking a decrease of 14.00 Cr..
- For EPS in Rs, as of Jun 2025, the value is 1.38. The value appears to be declining and may need further review. It has decreased from 2.99 (Mar 2025) to 1.38, marking a decrease of 1.61.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 4:58 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 477 | 499 | 526 | 608 | 704 | 793 | 745 | 404 | 830 | 1,310 | 1,211 | 1,107 | 1,049 |
| Expenses | 402 | 435 | 460 | 490 | 556 | 637 | 625 | 374 | 710 | 930 | 860 | 860 | 838 |
| Operating Profit | 76 | 64 | 65 | 118 | 148 | 156 | 119 | 30 | 120 | 380 | 351 | 247 | 211 |
| OPM % | 16% | 13% | 12% | 19% | 21% | 20% | 16% | 7% | 14% | 29% | 29% | 22% | 20% |
| Other Income | 3 | 1 | 1 | 3 | 3 | 9 | 9 | 1 | 4 | -60 | -12 | 3 | 7 |
| Interest | 22 | 21 | 20 | 21 | 25 | 29 | 31 | 28 | 70 | 71 | 44 | 40 | 41 |
| Depreciation | 19 | 13 | 14 | 15 | 19 | 25 | 32 | 35 | 46 | 45 | 48 | 54 | 57 |
| Profit before tax | 37 | 32 | 33 | 84 | 107 | 111 | 65 | -32 | 8 | 203 | 248 | 155 | 121 |
| Tax % | 10% | 21% | 25% | 30% | 32% | 30% | -10% | -60% | -74% | 33% | 26% | 26% | |
| Net Profit | 34 | 25 | 25 | 59 | 73 | 78 | 72 | -13 | 13 | 136 | 184 | 115 | 89 |
| EPS in Rs | 3.84 | 2.87 | 2.81 | 6.79 | 8.35 | 8.93 | 8.23 | -1.46 | 1.54 | 15.60 | 21.07 | 13.20 | 10.20 |
| Dividend Payout % | 0% | 3% | 4% | 3% | 3% | 6% | 3% | 0% | 0% | 19% | 14% | 23% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.47% | 0.00% | 136.00% | 23.73% | 6.85% | -7.69% | -118.06% | 200.00% | 946.15% | 35.29% | -37.50% |
| Change in YoY Net Profit Growth (%) | 0.00% | 26.47% | 136.00% | -112.27% | -16.88% | -14.54% | -110.36% | 318.06% | 746.15% | -910.86% | -72.79% |
Kuantum Papers Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 8% |
| 5 Years: | 8% |
| 3 Years: | 10% |
| TTM: | -11% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 10% |
| 3 Years: | 105% |
| TTM: | -43% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 17% |
| 3 Years: | -1% |
| 1 Year: | -24% |
| Return on Equity | |
|---|---|
| 10 Years: | 10% |
| 5 Years: | 11% |
| 3 Years: | 16% |
| Last Year: | 10% |
Last Updated: September 5, 2025, 9:25 am
Balance Sheet
Last Updated: August 11, 2025, 2:14 pm
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 |
| Reserves | 100 | 532 | 552 | 612 | 683 | 758 | 823 | 809 | 822 | 958 | 1,115 | 1,204 |
| Borrowings | 177 | 224 | 243 | 302 | 321 | 395 | 573 | 689 | 762 | 513 | 512 | 654 |
| Other Liabilities | 94 | 91 | 100 | 88 | 109 | 123 | 144 | 108 | 83 | 210 | 251 | 246 |
| Total Liabilities | 379 | 856 | 903 | 1,011 | 1,121 | 1,284 | 1,549 | 1,614 | 1,676 | 1,689 | 1,888 | 2,113 |
| Fixed Assets | 265 | 673 | 687 | 772 | 825 | 978 | 1,034 | 1,436 | 1,408 | 1,414 | 1,475 | 1,619 |
| CWIP | 0 | 26 | 50 | 42 | 84 | 55 | 310 | 21 | 29 | 31 | 42 | 156 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 114 | 157 | 166 | 198 | 213 | 251 | 206 | 158 | 239 | 245 | 371 | 338 |
| Total Assets | 379 | 856 | 903 | 1,011 | 1,121 | 1,284 | 1,549 | 1,614 | 1,676 | 1,689 | 1,888 | 2,113 |
Below is a detailed analysis of the balance sheet data for Kuantum Papers Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:
- For Equity Capital, as of Mar 2025, the value is 9.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 9.00 Cr..
- For Reserves, as of Mar 2025, the value is 1,204.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,115.00 Cr. (Mar 2024) to 1,204.00 Cr., marking an increase of 89.00 Cr..
- For Borrowings, as of Mar 2025, the value is 654.00 Cr.. The value appears to be increasing, which may not be favorable. Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has increased from 512.00 Cr. (Mar 2024) to 654.00 Cr., marking an increase of 142.00 Cr..
- For Other Liabilities, as of Mar 2025, the value is 246.00 Cr.. The value appears to be improving (decreasing). It has decreased from 251.00 Cr. (Mar 2024) to 246.00 Cr., marking a decrease of 5.00 Cr..
- For Total Liabilities, as of Mar 2025, the value is 2,113.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 1,888.00 Cr. (Mar 2024) to 2,113.00 Cr., marking an increase of 225.00 Cr..
- For Fixed Assets, as of Mar 2025, the value is 1,619.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,475.00 Cr. (Mar 2024) to 1,619.00 Cr., marking an increase of 144.00 Cr..
- For CWIP, as of Mar 2025, the value is 156.00 Cr.. The value appears strong and on an upward trend. It has increased from 42.00 Cr. (Mar 2024) to 156.00 Cr., marking an increase of 114.00 Cr..
- For Investments, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
- For Other Assets, as of Mar 2025, the value is 338.00 Cr.. The value appears to be declining and may need further review. It has decreased from 371.00 Cr. (Mar 2024) to 338.00 Cr., marking a decrease of 33.00 Cr..
- For Total Assets, as of Mar 2025, the value is 2,113.00 Cr.. The value appears strong and on an upward trend. It has increased from 1,888.00 Cr. (Mar 2024) to 2,113.00 Cr., marking an increase of 225.00 Cr..
Notably, the Reserves (1,204.00 Cr.) exceed the Borrowings (654.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow - No data available for this post.
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | -101.00 | -160.00 | -178.00 | -184.00 | -173.00 | -239.00 | -454.00 | -659.00 | -642.00 | -133.00 | -161.00 | -407.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 27 | 32 | 25 | 21 | 17 | 15 | 7 | 30 | 27 | 8 | 10 | 13 |
| Inventory Days | 105 | 107 | 102 | 117 | 133 | 95 | 141 | 145 | 114 | 88 | 126 | 141 |
| Days Payable | 89 | 54 | 47 | 47 | 54 | 47 | 42 | 124 | 47 | 25 | 64 | 47 |
| Cash Conversion Cycle | 43 | 85 | 80 | 91 | 95 | 63 | 105 | 51 | 94 | 71 | 73 | 107 |
| Working Capital Days | -33 | -4 | -4 | -6 | -0 | -5 | -19 | -17 | 10 | -4 | -22 | -25 |
| ROCE % | 21% | 10% | 7% | 12% | 14% | 13% | 8% | 0% | 5% | 22% | 20% | 11% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 1.00 | 1.00 | 1.00 | 1.00 | 1.00 |
| Basic EPS (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| Diluted EPS (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| Cash EPS (Rs.) | 19.39 | 26.59 | 20.81 | 6.83 | 2.53 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 138.97 | 128.79 | 110.79 | 95.17 | 93.65 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 138.97 | 128.79 | 110.79 | 95.17 | 93.65 |
| Dividend / Share (Rs.) | 3.00 | 3.00 | 0.00 | 0.00 | 0.00 |
| Revenue From Operations / Share (Rs.) | 126.86 | 138.81 | 150.07 | 95.16 | 46.28 |
| PBDIT / Share (Rs.) | 28.50 | 38.81 | 43.87 | 14.07 | 4.51 |
| PBIT / Share (Rs.) | 22.31 | 33.28 | 38.66 | 8.78 | 0.51 |
| PBT / Share (Rs.) | 17.81 | 28.37 | 23.26 | 0.88 | -3.65 |
| Net Profit / Share (Rs.) | 13.20 | 21.07 | 15.60 | 1.54 | -1.46 |
| PBDIT Margin (%) | 22.46 | 27.96 | 29.23 | 14.78 | 9.73 |
| PBIT Margin (%) | 17.58 | 23.97 | 25.76 | 9.23 | 1.11 |
| PBT Margin (%) | 14.03 | 20.44 | 15.49 | 0.92 | -7.88 |
| Net Profit Margin (%) | 10.40 | 15.17 | 10.39 | 1.61 | -3.15 |
| Return on Networth / Equity (%) | 9.49 | 16.35 | 14.08 | 1.61 | -1.55 |
| Return on Capital Employeed (%) | 10.90 | 18.31 | 22.78 | 5.10 | 0.30 |
| Return On Assets (%) | 5.45 | 9.73 | 8.05 | 0.80 | -0.78 |
| Long Term Debt / Equity (X) | 0.33 | 0.27 | 0.34 | 0.74 | 0.71 |
| Total Debt / Equity (X) | 0.53 | 0.45 | 0.49 | 0.88 | 0.78 |
| Asset Turnover Ratio (%) | 0.55 | 0.67 | 0.77 | 0.50 | 0.25 |
| Current Ratio (X) | 0.83 | 1.02 | 1.02 | 1.23 | 0.98 |
| Quick Ratio (X) | 0.44 | 0.64 | 0.58 | 0.73 | 0.63 |
| Inventory Turnover Ratio (X) | 9.26 | 3.55 | 4.50 | 4.31 | 1.90 |
| Dividend Payout Ratio (NP) (%) | 22.72 | 14.24 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 15.47 | 11.28 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 77.28 | 85.76 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 84.53 | 88.72 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 6.33 | 7.90 | 5.39 | 1.78 | 1.42 |
| Interest Coverage Ratio (Post Tax) (X) | 3.93 | 5.29 | 3.81 | 1.19 | 0.85 |
| Enterprise Value (Cr.) | 1512.26 | 1786.29 | 1555.37 | 1448.18 | 1240.79 |
| EV / Net Operating Revenue (X) | 1.37 | 1.47 | 1.19 | 1.74 | 3.07 |
| EV / EBITDA (X) | 6.08 | 5.27 | 4.06 | 11.79 | 31.55 |
| MarketCap / Net Operating Revenue (X) | 0.79 | 1.12 | 0.80 | 0.84 | 1.44 |
| Retention Ratios (%) | 77.27 | 85.75 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 0.72 | 1.20 | 1.10 | 0.84 | 0.71 |
| Price / Net Operating Revenue (X) | 0.79 | 1.12 | 0.80 | 0.84 | 1.44 |
| EarningsYield | 0.13 | 0.13 | 0.12 | 0.01 | -0.02 |
After reviewing the key financial ratios for Kuantum Papers Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 1.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 1.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For Diluted EPS (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For Cash EPS (Rs.), as of Mar 25, the value is 19.39. This value is within the healthy range. It has decreased from 26.59 (Mar 24) to 19.39, marking a decrease of 7.20.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 138.97. It has increased from 128.79 (Mar 24) to 138.97, marking an increase of 10.18.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 138.97. It has increased from 128.79 (Mar 24) to 138.97, marking an increase of 10.18.
- For Dividend / Share (Rs.), as of Mar 25, the value is 3.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 3.00.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 126.86. It has decreased from 138.81 (Mar 24) to 126.86, marking a decrease of 11.95.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 28.50. This value is within the healthy range. It has decreased from 38.81 (Mar 24) to 28.50, marking a decrease of 10.31.
- For PBIT / Share (Rs.), as of Mar 25, the value is 22.31. This value is within the healthy range. It has decreased from 33.28 (Mar 24) to 22.31, marking a decrease of 10.97.
- For PBT / Share (Rs.), as of Mar 25, the value is 17.81. This value is within the healthy range. It has decreased from 28.37 (Mar 24) to 17.81, marking a decrease of 10.56.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 13.20. This value is within the healthy range. It has decreased from 21.07 (Mar 24) to 13.20, marking a decrease of 7.87.
- For PBDIT Margin (%), as of Mar 25, the value is 22.46. This value is within the healthy range. It has decreased from 27.96 (Mar 24) to 22.46, marking a decrease of 5.50.
- For PBIT Margin (%), as of Mar 25, the value is 17.58. This value is within the healthy range. It has decreased from 23.97 (Mar 24) to 17.58, marking a decrease of 6.39.
- For PBT Margin (%), as of Mar 25, the value is 14.03. This value is within the healthy range. It has decreased from 20.44 (Mar 24) to 14.03, marking a decrease of 6.41.
- For Net Profit Margin (%), as of Mar 25, the value is 10.40. This value exceeds the healthy maximum of 10. It has decreased from 15.17 (Mar 24) to 10.40, marking a decrease of 4.77.
- For Return on Networth / Equity (%), as of Mar 25, the value is 9.49. This value is below the healthy minimum of 15. It has decreased from 16.35 (Mar 24) to 9.49, marking a decrease of 6.86.
- For Return on Capital Employeed (%), as of Mar 25, the value is 10.90. This value is within the healthy range. It has decreased from 18.31 (Mar 24) to 10.90, marking a decrease of 7.41.
- For Return On Assets (%), as of Mar 25, the value is 5.45. This value is within the healthy range. It has decreased from 9.73 (Mar 24) to 5.45, marking a decrease of 4.28.
- For Long Term Debt / Equity (X), as of Mar 25, the value is 0.33. This value is within the healthy range. It has increased from 0.27 (Mar 24) to 0.33, marking an increase of 0.06.
- For Total Debt / Equity (X), as of Mar 25, the value is 0.53. This value is within the healthy range. It has increased from 0.45 (Mar 24) to 0.53, marking an increase of 0.08.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 0.55. It has decreased from 0.67 (Mar 24) to 0.55, marking a decrease of 0.12.
- For Current Ratio (X), as of Mar 25, the value is 0.83. This value is below the healthy minimum of 1.5. It has decreased from 1.02 (Mar 24) to 0.83, marking a decrease of 0.19.
- For Quick Ratio (X), as of Mar 25, the value is 0.44. This value is below the healthy minimum of 1. It has decreased from 0.64 (Mar 24) to 0.44, marking a decrease of 0.20.
- For Inventory Turnover Ratio (X), as of Mar 25, the value is 9.26. This value exceeds the healthy maximum of 8. It has increased from 3.55 (Mar 24) to 9.26, marking an increase of 5.71.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 22.72. This value is within the healthy range. It has increased from 14.24 (Mar 24) to 22.72, marking an increase of 8.48.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 15.47. This value is below the healthy minimum of 20. It has increased from 11.28 (Mar 24) to 15.47, marking an increase of 4.19.
- For Earning Retention Ratio (%), as of Mar 25, the value is 77.28. This value exceeds the healthy maximum of 70. It has decreased from 85.76 (Mar 24) to 77.28, marking a decrease of 8.48.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 84.53. This value exceeds the healthy maximum of 70. It has decreased from 88.72 (Mar 24) to 84.53, marking a decrease of 4.19.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 6.33. This value is within the healthy range. It has decreased from 7.90 (Mar 24) to 6.33, marking a decrease of 1.57.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 3.93. This value is within the healthy range. It has decreased from 5.29 (Mar 24) to 3.93, marking a decrease of 1.36.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,512.26. It has decreased from 1,786.29 (Mar 24) to 1,512.26, marking a decrease of 274.03.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 1.37. This value is within the healthy range. It has decreased from 1.47 (Mar 24) to 1.37, marking a decrease of 0.10.
- For EV / EBITDA (X), as of Mar 25, the value is 6.08. This value is within the healthy range. It has increased from 5.27 (Mar 24) to 6.08, marking an increase of 0.81.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.79, marking a decrease of 0.33.
- For Retention Ratios (%), as of Mar 25, the value is 77.27. This value exceeds the healthy maximum of 70. It has decreased from 85.75 (Mar 24) to 77.27, marking a decrease of 8.48.
- For Price / BV (X), as of Mar 25, the value is 0.72. This value is below the healthy minimum of 1. It has decreased from 1.20 (Mar 24) to 0.72, marking a decrease of 0.48.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 0.79. This value is below the healthy minimum of 1. It has decreased from 1.12 (Mar 24) to 0.79, marking a decrease of 0.33.
- For EarningsYield, as of Mar 25, the value is 0.13. This value is below the healthy minimum of 5. There is no change compared to the previous period (Mar 24) which recorded 0.13.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Kuantum Papers Ltd:
- Net Profit Margin: 10.4%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 10.9% (Industry Average ROCE: 8.47%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 9.49% (Industry Average ROE: 110.29%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 3.93
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 0.44
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 12.5 (Industry average Stock P/E: 30.78)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0.53
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.4%
Fundamental Analysis of Kuantum Papers Ltd
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Paper & Paper Products | Paper Mill, Distt Hoshiarpur, Sailakhurd Punjab 144529 | kuantumcorp@kuantumpapers.com http://www.kuantumpapers.com |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Jagesh Kumar Khaitan | Chairman |
| Mr. Pavan Khaitan | Vice Chairman & Mng.Director |
| Mr. Bhavdeep Sardana | Independent Director |
| Mr. Vivek Bihani | Independent Director |
| Mr. Shireen Sethi | Independent Director |
| Mr. Drishinder Singh Sandhawalia | Non Exe.Non Ind.Director |
Kuantum Papers Ltd. Share Price Update | |
|---|---|
| Share Price | Value |
| Today | ₹159.45 |
| Previous Day | ₹155.15 |
FAQ
What is the intrinsic value of Kuantum Papers Ltd?
Kuantum Papers Ltd's intrinsic value (as of 09 December 2025) is 143.90 which is 54.73% higher the current market price of 93.00, indicating undervalued. Calculated using the PE ratio method, this valuation considers the company's 812 Cr. market cap, FY2025-2026 high/low of 148/87.8, reserves of ₹1,204 Cr, and liabilities of 2,113 Cr.
What is the Market Cap of Kuantum Papers Ltd?
The Market Cap of Kuantum Papers Ltd is 812 Cr..
What is the current Stock Price of Kuantum Papers Ltd as on 09 December 2025?
The current stock price of Kuantum Papers Ltd as on 09 December 2025 is 93.0.
What is the High / Low of Kuantum Papers Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Kuantum Papers Ltd stocks is 148/87.8.
What is the Stock P/E of Kuantum Papers Ltd?
The Stock P/E of Kuantum Papers Ltd is 12.5.
What is the Book Value of Kuantum Papers Ltd?
The Book Value of Kuantum Papers Ltd is 138.
What is the Dividend Yield of Kuantum Papers Ltd?
The Dividend Yield of Kuantum Papers Ltd is 3.24 %.
What is the ROCE of Kuantum Papers Ltd?
The ROCE of Kuantum Papers Ltd is 11.4 %.
What is the ROE of Kuantum Papers Ltd?
The ROE of Kuantum Papers Ltd is 10.1 %.
What is the Face Value of Kuantum Papers Ltd?
The Face Value of Kuantum Papers Ltd is 1.00.